PCM
MDCO

Price Capital Management’s Medicines Co MDCO Stock Holding History

Price Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19,414
Closed -$712K – 196
2018
Q2 		$712K Buy
+19,414
New +$631K 0.35% 84

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Price Capital Management's MDCO Position: Q3 2018 in Review

Price Capital Management sold out of Medicines Co (MDCO) in Q3 2018, closing a stake of 19,414 shares — an estimated $712K sold.

Price Capital Management first reported a position in MDCO in Q2 2018 and held it in 1 quarter. The position peaked at $712K in Q2 2018. 184 funds tracked by Wall St. Rank hold MDCO as of Q3 2018.

  • Price Capital Management reported no remaining Medicines Co position as of Q3 2018 after selling out during the quarter.
  • Price Capital Management sold 19,414 Medicines Co shares in Q3 2018, an estimated $712K.
  • Price Capital Management first reported a position in Medicines Co in Q2 2018 and held it in 1 quarter.
  • Price Capital Management's Medicines Co position peaked at $712K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Medicines Co as of Q3 2018.

Based on Price Capital Management's 13F filing for Q3 2018, filed 29 Oct 2018.